Printed in U.S.A. Copyright © 2001 by The Endocrine Society Minireview: 11�-Hydroxysteroid Dehydrogenase Type 1— A Tissue-Specific Amplifier of Glucocorticoid Action*
暂无分享,去创建一个
[1] A. Boulton,et al. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity. , 1999, The Journal of clinical endocrinology and metabolism.
[2] D. Morris,et al. Localization of 2 11β-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells , 1998 .
[3] F. Frey,et al. Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. , 1999, The Journal of clinical endocrinology and metabolism.
[4] P. Stewart,et al. Localization of renal 11 beta-dehydrogenase by in situ hybridization: autocrine not paracrine protector of the mineralocorticoid receptor. , 1991, Endocrinology.
[5] T. Conca,et al. The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3 alpha- and 3 beta-hydroxysteroid dehydrogenases and 5 alpha- and 5 beta-reductase pathways of metabolism of aldosterone in male rats. , 1990, Steroids.
[6] P. Stewart,et al. 11 beta-Hydroxysteroid dehydrogenase. , 1994, Vitamins and hormones.
[7] M. Nyirenda,et al. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1. , 1999, The Journal of endocrinology.
[8] C. Edwards,et al. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. , 1990, Endocrinology.
[9] D. Morris,et al. Bidirectional activity of 11β-hydroxysteroid dehydrogenase in vascular smooth muscle cells , 1995, Steroids.
[10] J. Funder,et al. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. , 1988, Science.
[11] M. Tusié-Luna,et al. Expression of 11β-Hydroxysteroid Dehydrogenase Using Recombinant Vaccinia Virus , 1990 .
[12] I. Robinson,et al. Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. , 1994, The Journal of endocrinology.
[13] B. Walker,et al. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. , 1991, Endocrinology.
[14] D. Webb,et al. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. , 1995, The Journal of clinical endocrinology and metabolism.
[15] M. New,et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. , 1979, The Journal of clinical endocrinology and metabolism.
[16] C. Edwards,et al. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.
[17] J. Balfe,et al. Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. , 1998, The Journal of clinical endocrinology and metabolism.
[18] G. Meyerheim,et al. Conversion of cortisone to compound F. , 1953, The Journal of clinical endocrinology and metabolism.
[19] C. Edwards,et al. 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. , 1995, Endocrinology.
[20] D. Webb,et al. Cortisol inhibits cholinergic vasodilation in the human forearm. , 2000, American journal of hypertension.
[21] T. Olsson,et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. , 2001, The Journal of clinical endocrinology and metabolism.
[22] C. Edwards,et al. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. , 1999, The Journal of clinical investigation.
[23] B. McEwen,et al. Differential inhibition of 11β-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[24] B. Walker,et al. - Hydroxysteroid dehydrogenase type 1 is a predominant 11-reductase in the intact perfused rat liver , 2000 .
[25] J. Seckl,et al. Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] Z. Krozowski,et al. Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme , 1994, Molecular and Cellular Endocrinology.
[27] B. Walker,et al. 11 beta-hydroxysteroid dehydrogenase type 1 is a predominant 11 beta-reductase in the intact perfused rat liver. , 2000, The Journal of endocrinology.
[28] R. Clayton,et al. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. , 1994, The New England journal of medicine.
[29] V. Poli,et al. C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. , 2000, The Journal of biological chemistry.
[30] B. Walker,et al. Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension , 1993, Clinical endocrinology.
[31] J. Connell,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Apparent Cortisone Reductase Deficiency: A Functional Defect in 11�-Hydroxysteroid Dehydrogenase Type 1* , 2022 .
[32] J. Seckl,et al. 11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[33] D. Webb,et al. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. , 1992, Clinical science.
[34] D. Morris,et al. Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells. , 1998, Hypertension.
[35] T. Mune,et al. NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. , 1994, The Journal of biological chemistry.
[36] Margaret S. Wu,et al. PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver , 2000 .
[37] H. J. Harris,et al. Intracellular Regeneration of Glucocorticoids by 11β-Hydroxysteroid Dehydrogenase (11β-HSD)-1 Plays a Key Role in Regulation of the Hypothalamic-Pituitary-Adrenal Axis: Analysis of 11β-HSD-1-Deficient Mice1 , 2001 .
[38] J. Seckl,et al. 11beta-hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells. , 1998, The Journal of endocrinology.
[39] B. Walker,et al. Mineralocorticoid excess and inhibition of 11 β‐hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome , 1992, Clinical endocrinology.
[40] K. Noonan,et al. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults , 1994, Clinical endocrinology.
[41] P. Stewart,et al. Does central obesity reflect “Cushing's disease of the omentum”? , 1997, The Lancet.
[42] D. Housman,et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. , 1987, Science.
[43] Edwards,et al. 11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress , 1997 .
[44] P. White,et al. 11 beta-hydroxysteroid dehydrogenase. , 1993, Vitamins and hormones.
[45] B. Walker,et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. , 2000, Endocrinology.
[46] P. Stewart,et al. 7 11-hydroxysteroid dehydrogenase , 1994 .
[47] S. Coppack,et al. An in vivo study of the cortisol–cortisone shuttle in subcutaneous abdominal adipose tissue , 1999, Clinical endocrinology.
[48] J. Funder,et al. Mineralocorticoid specificity of renal type I receptors: in vivo binding studies. , 1987, The American journal of physiology.
[49] C. Edwards,et al. Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. , 1993, Endocrinology.
[50] P. Stewart,et al. MINERALOCORTICOID ACTIVITY OF LIQUORICE: 11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY COMES OF AGE , 1987, The Lancet.
[51] P. White,et al. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. , 1989, The Journal of biological chemistry.
[52] J. Seckl,et al. Tissue- and temporal-specific regulation of 11β-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[53] R. Sapolsky,et al. In vivo Characterization of 11β-Hydroxysteroid Dehydrogenase in Rat Hippocampus Using Glucocorticoid Neuroendangerment as an Endpoint , 1999, Neuroendocrinology.
[54] J. Whitworth,et al. THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MAN , 1989, Clinical endocrinology.
[55] G. Phillipov,et al. Apparent cortisone reductase deficiency: a unique form of hypercortisolism. , 1996, The Journal of clinical endocrinology and metabolism.
[56] M. Hardy,et al. 11 beta-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. , 1994, Endocrinology.
[57] C. Monder,et al. Purification and Characterization of the Corticosteroid 1lβ-Dehydrogenase Component of the Rat Liver 1lβ-Hydroxysteroid Dehydrogenase Complex* , 1988 .
[58] D. Schomburg,et al. 11beta-Hydroxysteroid dehydrogenase , 1995 .